CIK: 0001646343
Total reported value
$120.1M
| # | Ticker | Issuer | Asset Subclass | Weight | Weight Change | Shares Change | 4Q Trend |
|---|---|---|---|---|---|---|---|
| 1 | ✓ | Shire PLC | Stock-Other | 12.98% | — | +94.03% | |
| 2 | NVS | Novartis Ag-sponsored Adr | Stock-Healthcare | 8.45% | -4.65% | EXIT | |
| 3 | CELG | Celgene CORP | Stock-Other | 8.28% | — | — | |
| 4 | ALXN | Alexion Pharmaceuticals INC | Stock-Other | 7.17% | — | — | |
| 5 | PFE | Pfizer INC | Stock-Healthcare | 6.06% | — | -51.37% | |
| 6 | AZNN | Astrazeneca Plc-spons Adr | Stock-Other | 4.80% | — | — | |
| 7 | ✓ | Horizon Pharma PLC | Stock-Other | 4.74% | — | — | |
| 8 | AZN | AstraZeneca PLC | Stock-Healthcare | 4.00% | — | — | |
| 9 | KRG | Kite Realty Group Trust | Stock-Real Estate | 3.94% | — | — | |
| 10 | ✓ | Tesaro INC | Stock-Other | 3.94% | — | — | |
| 11 | ALNY | Alnylam Pharmaceuticals INC | Stock-Healthcare | 3.62% | — | — | |
| 12 | NERVGBP | Minerva Neurosciences INC | Stock-Other | 3.40% | — | — | |
| 13 | NBIX | Neurocrine Biosciences INC | Stock-Healthcare | 2.72% | +3.93% | — | |
| 14 | XLRN | Acceleron Pharma INC | Stock-Other | 2.66% | — | -18.28% | |
| 15 | INSM | Insmed INC | Stock-Healthcare | 2.50% | +0.01% | — | |
| 16 | CLDNEUR | Eiger Biopharmaceuticals INC | Stock-Other | 1.80% | — | -0.15% | |
| 17 | ABEO1EUR | Abeona Therapeutics INC | Stock-Other | 1.62% | — | +76.79% | |
| 18 | ADMSEUR | Adamas Pharmaceuticals INC | Stock-Other | 1.50% | — | -45.59% | |
| 19 | FGENEUR | Fibrogen INC | Stock-Other | 1.45% | — | -9.15% | |
| 20 | ✓ | Trevena INC | Stock-Other | 1.37% | — | +33.46% | |
| 21 | CARAEUR | Cara Therapeutics INC | Stock-Other | 1.36% | — | — | |
| 22 | ✓ | Newlink Genetics CORP | Stock-Other | 1.21% | — | — | |
| 23 | ASND | Ascendis Pharma A/S | Stock-Other | 1.19% | +5.78% | NEW | |
| 24 | ZGNXEUR | Zogenix INC | Stock-Other | 1.07% | — | -42.31% | |
| 25 | CNCEEUR | Concert Pharmaceuticals INC | Stock-Other | 1.01% | — | — | |
| 26 | PRTKEUR | Paratek Pharmaceuticals INC | Stock-Other | 0.90% | — | — | |
| 27 | SGMOQ | Sangamo Therapeutics INC | Stock-Other | 0.90% | — | — | |
| 28 | ✓ | Advaxis | Stock-Other | 0.84% | — | — | |
| 29 | ✓ | Axovant Sciences LTD | Stock-Other | 0.73% | — | — | |
| 30 | IMRX | Immuneering Corporation | Stock-Other | 0.64% | — | -34.89% | |
| 31 | CLSDUSD | Clearside Biomedical INC | Stock-Other | 0.63% | — | — | |
| 32 | RDHLGBP | Redhill Biopharma Ltd-sp Adr | Stock-Other | 0.58% | — | — | |
| 33 | GBTUSD | Global Blood Therapeutics In | Stock-Other | 0.51% | +0.64% | — | |
| 34 | ✓ | Intec Pharma LTD Jerusalem | Stock-Other | 0.46% | — | — | |
| 35 | VTGNUSD | Vistagen Therapeutics INC | Stock-Other | 0.30% | — | — | |
| 36 | ✓ | Amicus Therapeutics INC | Stock-Other | 0.29% | — | — | |
| 37 | ✓ | Veralto CORP | Stock-Other | 0.22% | — | — | |
| 38 | ✓ | Stock-Other | 0.09% | — | — | ||
| 39 | ✓ | Tracon Pharmaceuticals INC | Stock-Other | 0.04% | — | — |
| # | Ticker | Issuer | Weight Change | Shares Change | Action |
|---|---|---|---|---|---|
| 1 | ✓ | Shire PLC | +5% | +94.03% | Add |
| 2 | ABEO1EUR | Abeona Therapeutics INC | +0.4% | +76.79% | Add |
| 3 | ✓ | Trevena INC | +0.1% | +33.46% | Add |
| 4 | ✓ | Veralto CORP | -0.1% | — | Unchanged |
| 5 | FGENEUR | Fibrogen INC | -0.2% | -9.15% | Trim |
| 6 | CLDNEUR | Eiger Biopharmaceuticals INC | -0.4% | -0.15% | Trim |
| 7 | INSM | Insmed INC | -0.4% | — | Unchanged |
| 8 | ✓ | Advaxis | -0.5% | — | Unchanged |
| 9 | ASND | Ascendis Pharma A/S | -0.6% | -31.60% | Trim |
| 10 | ZGNXEUR | Zogenix INC | -0.8% | -42.31% | Trim |
| 11 | IMRX | Immuneering Corporation | -0.8% | -34.89% | Trim |
| 12 | AZN | AstraZeneca PLC | -1.1% | — | Unchanged |
| 13 | ADMSEUR | Adamas Pharmaceuticals INC | -1.3% | -45.59% | Trim |
| 14 | XLRN | Acceleron Pharma INC | -2.2% | -18.28% | Trim |
| 15 | PFE | Pfizer INC | -7.6% | -51.37% | Trim |
| 16 | ✓ | Spdr Series Trust | — | EXIT | Sold out |
| 17 | GSK | GSK plc ADRhedged | — | EXIT | Sold out |
| 18 | NVS | Novartis Ag-sponsored Adr | — | NEW | New buy |
| 19 | CELG | Celgene CORP | — | NEW | New buy |
| 20 | ALXN | Alexion Pharmaceuticals INC | — | NEW | New buy |
| 21 | AZNN | Astrazeneca Plc-spons Adr | — | NEW | New buy |
| 22 | ✓ | Horizon Pharma PLC | — | NEW | New buy |
| 23 | KRG | Kite Realty Group Trust | — | NEW | New buy |
| 24 | ✓ | Tesaro INC | — | NEW | New buy |
| 25 | ALNY | Alnylam Pharmaceuticals INC | — | NEW | New buy |
| 26 | SGENEUR | Seagen INC | — | EXIT | Sold out |
| 27 | NERVGBP | Minerva Neurosciences INC | — | NEW | New buy |
| 28 | NBIX | Neurocrine Biosciences INC | — | NEW | New buy |
| 29 | ✓ | Aquinox Pharmaceuticals INC Bc | — | EXIT | Sold out |
| 30 | LN5 | Lannett Co INC | — | EXIT | Sold out |
| 31 | CLVSEUR | Clovis Oncology INC | — | EXIT | Sold out |
| 32 | IMMU | Immunomedics INC | — | EXIT | Sold out |
| 33 | ✓ | Colucid Pharmaceuticals Inc Com | — | EXIT | Sold out |
| 34 | ✓ | Neuroderm LTD | — | EXIT | Sold out |
| 35 | CARAEUR | Cara Therapeutics INC | — | NEW | New buy |
| 36 | PGNXUSD | Progenics Pharmaceuticals | — | EXIT | Sold out |
| 37 | ✓ | Newlink Genetics CORP | — | NEW | New buy |
| 38 | AERIEUR | Aerie Pharmaceuticals INC | — | EXIT | Sold out |
| 39 | PRTKEUR | Paratek Pharmaceuticals INC | — | NEW | New buy |
| 40 | SGMOQ | Sangamo Therapeutics INC | — | NEW | New buy |
| 41 | ✓ | Axovant Sciences LTD | — | EXIT | Sold out |
| 42 | ✓ | Axovant Sciences LTD | — | NEW | New buy |
| 43 | ✓ | Foamix Pharmaceuticals LTD | — | EXIT | Sold out |
| 44 | ✓ | Ophthotech Corporation | — | EXIT | Sold out |
| 45 | CLSDUSD | Clearside Biomedical INC | — | NEW | New buy |
| 46 | RDHLGBP | Redhill Biopharma Ltd-sp Adr | — | NEW | New buy |
| 47 | GBTUSD | Global Blood Therapeutics In | — | NEW | New buy |
| 48 | ✓ | Intec Pharma LTD Jerusalem | — | NEW | New buy |
| 49 | ✓ | Amicus Therapeutics INC | — | NEW | New buy |
| 50 | ✓ | Tracon Pharmaceuticals INC | — | NEW | New buy |